Skip to main content
Livermore
Livermore
ZHEN

Revelation Biosciences, Inc.

REVB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001810560

No open-market purchases or sales by Revelation Biosciences, Inc. insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $313.2K in total; no superinvestor holds it.

Other share classesREVBW

Holders of 5% or more of REVB

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Revelation Biosciences, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of REVB
HolderLatest formStakeChangeFirst filedLatest filingFiling
Sabby Management, LLC13G9.60%605.7K sharesNewJan 20, 20261 filingJan 20, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

34 Schedule 13D and 13G filings on Revelation Biosciences, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on REVB
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 202610:24 AM ETArmistice Capital, LLCand 1 other13G/A4.99%209.2K shares−2.81 ppfrom 7.80%Below 5%Jun 30, 2026SEC
May 15, 202611:34 AM ETArmistice Capital, LLCand 1 other13G7.80%323.2K sharesNewMar 31, 2026SEC
Feb 17, 20269:37 PM ETArmistice Capital, LLCand 1 other13G/A4.99%288.3K shares−5.00 ppfrom 9.99%Below 5%Dec 31, 2025SEC
Jan 20, 20268:31 PM ETSabby Management, LLCand 2 others13G9.60%605.7K sharesNewDec 31, 2025SEC
Nov 14, 20256:15 PM ETArmistice Capital, LLCand 1 other13G9.99%250.8K sharesNewSep 30, 2025SEC
Jan 2, 20258:40 PM ETSabby Management, LLCand 2 others13G/A4.90%417.0K shares–Below 5%Dec 31, 2024SEC
Feb 13, 2024Lind Global Fund II LP13G/AOld format–––SEC
Feb 12, 202410:19 AM ETAXA IM Prime Impact Master Fund I SCA SICAV-RAIFand 5 others13G/A0.90%56.0K shares–Below 5%Dec 31, 2023SEC
Jan 3, 2024Sabby Management, LLC13GOld format–New–SEC
Feb 21, 2023Intracoastal Capital, LLC13GOld format–New–SEC
Feb 21, 2023Lind Global Fund II LP13GOld format–New–SEC
Feb 14, 2023AXA IM Prime Impact Master Fund I SCA SICAV-RAIF13GOld format–New–SEC
Feb 6, 2023Weiss Asset Management LP13G/AOld format–––SEC
Jan 31, 2023Linden Capital L.P.13G/AOld format–––SEC
Aug 17, 2022Meteora Capital, LLC13G/AOld format–––SEC
Mar 24, 2022Meteora Capital, LLC13GOld format–New–SEC
Mar 10, 2022Karpus Management, Inc.13G/AOld format–––SEC
Feb 15, 2022Tidmarsh George F13DOld format–New–SEC
Feb 14, 2022Glazer Capital, LLC13G/AOld format–––SEC
Feb 14, 2022Karpus Management, Inc.13G/AOld format–––SEC
Feb 11, 2022Polar Asset Management Partners Inc.13G/AOld format–––SEC
Feb 9, 2022Weiss Asset Management LP13GOld format–New–SEC
Feb 4, 2022Hudson Bay Capital Management LP13G/AOld format–––SEC
Jan 20, 2022Linden Capital L.P.13GOld format–––SEC
Jan 11, 2022Feis Lawrence13G/AOld format–––SEC
Oct 12, 2021Feis Lawrence13G/AOld format–––SEC
Oct 12, 2021Glazer Capital, LLC13G/AOld format–––SEC
Sep 28, 2021Feis Lawrence13GOld format–New–SEC
Aug 10, 2021Karpus Management, Inc.13GOld format–New–SEC
Feb 16, 2021Glazer Capital, LLC13G/AOld format–––SEC
Feb 10, 2021Hudson Bay Capital Management LP13GOld format–New–SEC
Feb 10, 2021Polar Asset Management Partners Inc.13GOld format–New–SEC
Feb 8, 2021Linden Capital L.P.13G/AOld format–––SEC
Feb 5, 2021Boothbay Fund Management, LLC13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Revelation Biosciences, Inc. shares.

No Form 144 notices for Revelation Biosciences, Inc. are on file.